Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02817945|
Recruitment Status : Unknown
Verified November 2018 by Peking Union Medical College Hospital.
Recruitment status was: Recruiting
First Posted : June 29, 2016
Last Update Posted : November 5, 2018
|Condition or disease||Intervention/treatment||Phase|
|Lung Cancer||Drug: 68Ga-NOTA-3P-TATE-RGD||Early Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||68Ga-NOTA-3P-TATE-RGD for Dual Somatostatin Receptor and Integrin αvβ3 PET/CT Imaging of Lung Cancer and Neuroendocrine Neoplams|
|Study Start Date :||June 1, 2016|
|Estimated Primary Completion Date :||December 1, 2019|
|Estimated Study Completion Date :||December 31, 2019|
Experimental: 68Ga-NOTA-3P-TATE-RGD PET/CT
The patients were injected with 111-185 MBq of 68Ga-NOTA-3P-TATE-RGD in one dose intravenously and underwent PET/CT scan 45-60 min later.
68Ga-NOTA-3P-TATE-RGD were injected into the patients before the PET/CT scans
- Standardized uptake value of 68Ga-NOTA-3PTATE-RGD in lung cancer [ Time Frame: 1 year ]The semiquantitative analysis will be performed by the same person for all the cases, and the standardized uptake value (SUV) of the tracer in breast cancer will be measured.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02817945
|Contact: Zhaohui Zhu, MDemail@example.com|
|Contact: Shaobo Yao, PhDfirstname.lastname@example.org|
|Peking Union Medical College Hospitall, Chinese Academy of Medical Science and Peking Union Medical College||Recruiting|
|Beijing, Beijing, China, 100730|
|Contact: Zhaohui Zhu, MD +8613611093752 email@example.com|